Whilst both measured and estimated insulin sensitivity may vary with kidney disease severity [2, 24], clamp studies usually exclude people with moderate or severe kidney disease, and eGDR formulae specific for type 1 diabetic kidney disease have not been developed, nor have existent formulae been systematically assessed at different stages of kidney disease, although kidney disease is a major predictor of CAD. Here, INS is linked to kidney disorder.